down arrow

Sanjiv.Parant.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE860D01013
  • NSEID:
  • BSEID: 531569
INR
235.95
7 (3.06%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.69 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sanjivani Paranteral Ltd stock-summary
stock-summary
Sanjivani Paranteral Ltd
Micro Cap
Pharmaceuticals & Drugs
Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.
Company Coordinates stock-summary
Company Details
205 P N Khotari Indl Estate, LBS Marg Bhandup (West) Mumbai Maharashtra : 400078
stock-summary
Tel: 91-22-67290900
stock-summary
info@sanjivani.co.in
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 11.68 Cr
Number of Shares
1.17 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Feb-2024
1.17
11.68
1686000
10
Preferential Issue Of Shares
19-Aug-2021
99.98
10.00
1500000
10
Preferential basis
21-Jan-2021
84.98
8.50
2600000
10
Preferential basis
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ashwani Khemka (25.9%)

Highest Public shareholder

Suresh Pukhraj Jain . (6.8%)

Individual Investors Holdings

54.08%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Ashwin Khemka
Chairman & Managing Director
0
Mrunmai M Sarvankar
Independent Director
0
Shrenikkumar P Solanki
Independent Director
0
Monika Singhania
Independent Director
0
Srivardhan Ashwani Khemka
Director
0
Ritu Puglia
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Jobwork
2.55
14.22%
Export Incentives
0.12
0.68%
 
14.22
Jobwork
85.78
Jobwork
0.68
Export Incentives
99.32
Export Incentives
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
17 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 280 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

22.48%

stock-summary
Price to Book

8.53